4William House & the single-channel implant
The 1957 French experiment proved electrical hearing was possible; it did not produce anything a patient could take home. That step — from proof of principle to a device people could wear and use every day — was the work of one stubborn American otologist. William House of Los Angeles, partnered with the engineer Jack Urban, spent the 1960s and 1970s building, implanting, and refining a single-electrode cochlear implant, in the face of widespread scientific scepticism that it could ever convey useful hearing. His device was limited — one channel cannot carry speech well — but it worked, patients valued it, and it kept the whole field alive long enough for the multichannel era to arrive.
FThe surgeon who would not let go
William F. House, an otologist in Los Angeles (and a founder of modern neurotology), learned of the French nerve-stimulation work around 1960 and became convinced it could be turned into a treatment. Beginning in 1961, with the surgeon John Doyle, he implanted electrodes in deaf volunteers. Early devices failed — materials degraded, infection threatened — but House kept going where others gave up, treating each failure as an engineering problem rather than a refutation.[2013]
TBuilding a wearable device
The decisive partnership was with the engineer Jack Urban. Together, through the late 1960s and early 1970s, they solved the practical problems the French had not: a biocompatible electrode that could sit in the cochlea, a percutaneous or induction link, and a wearable external processor. By 1972 they had the first cochlear implant a patient could use in daily life — a single-channel device, later commercialised with the 3M company as the House/3M implant.[1973]
CWhat one channel could do
A single electrode delivers the whole of sound as one stream of stimulation. It therefore conveys the envelope of sound — its rhythm, timing, voicing and loudness — but not the spectral detail the normal cochlea encodes by place along its length (Chapter 2). In practice this meant single-channel users gained powerful benefits — awareness of environmental sound, the rhythm of speech, and above all a dramatic boost to lip-reading — but most could not understand running speech without watching the talker. It was real, useful hearing, and it was not enough.
CAgainst the experts
House's work drew sharp criticism. Prominent auditory physiologists argued that the cochlea was far too intricate to be meaningfully replaced by a single crude electrode, that electrical stimulation could never deliver speech, and that implanting such a device was raising false hope. Some regarded the venture as close to quackery. House persisted on the clinical evidence in front of him — patients who valued the device — and on the conviction that a limited result was a starting point, not a ceiling.
It is easy, in hindsight, to undersell the single-channel implant because multichannel devices later eclipsed it. But a treatment that restores sound awareness and transforms lip-reading is genuinely valuable to a deaf adult — and, just as important, House's patients were the living proof that electrical hearing was safe and real. Without that demonstration, the funding and credibility for the multichannel effort might never have materialised.
FTWhat House secured
House's device became, in 1984, the first cochlear implant approved by the FDA(for adults) — the regulatory beachhead the whole field would build on (Module 10). More fundamentally, he had converted Volta's and Djourno's principle into a manufactured, implantable, daily-use medical device, and had kept the enterprise alive through years when serious opinion held it to be impossible. The argument his critics raised — that one channel could not carry speech — was, however, substantially correct. Answering it would require not a better single electrode but a different architecture entirely.
That sets up the central scientific controversy of the chapter, the fight that determined what a cochlear implant would become — the single- versus multi-channel debate (Module 5).
How do you reconcile the delight with the poor speech score?
What was the principal limitation of the single-channel implant?
Why is William House's contribution historically pivotal despite the device's limits?